DigiPath (OTCQB:DIGP) reported that two cannabis strains tested in its Las Vegas lab had returned cannibinoid levels of over 30 percent. The two strains, Headcheese and True OG, were cultivated by Nevada’s Polaris MMJ.
As quoted in the press release:
After analyzing over six hundred cannabis flower samples, two separate cured cannabis flower samples were certified at 35.1% and 37.5% total cannabinoid content. The two strains in question, Headcheese and True OG, are new arrivals to the Las Vegas medical marijuana community through the cultivating efforts of Polaris MMJ. Cannabinoid levels coming in over 30% are unique, not just in Vegas but across the country.
A closer look at the breakdown of cannabinoids in these two strains reveals two unique profiles. The hybrid Headcheese strain produced not only a remarkable 31.35% THCA but an even lesser seen level of 2.46% CBGA, the chemical precursor molecule of both THCA and CBDA; while True OG came in with a whopping 35.9% THCA. From the terpenoid profiles, we observed high levels of myrcene (think mango, lemongrass, relaxed, happy) and isopulegol (the precursor to menthol) in the Headcheese strain while the True OG strain also had notable myrcene, limonene (love lemon) and linalool (anti-epileptic, lavender).
Digipath Labs Chief Science Officer, Cindy Orser, said:
Headcheese, a sativa-indica hybrid strain has attracted followings across the country due to its impressive THCA levels attributed to its astonishing analgesic benefits to alleviate migraines, inflammation, spasms and insomnia. The cured yellow-green brain-shaped flower buds have a lemon, pine, and cheese aroma leaving an earthy not fruity taste. The cheese-head effects are reportedly a total mind body experience, both relaxing and euphoric.